1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Subject:  Science & Technology

Results 1-20 of 65 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
13-Sep-2021A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)Chen, Yunxin ; Gopalakrishnan, Sathish Kumar; Ooi, Melissa ; Sultana, Rehena ; Lim, Li Hui; Grigoropoulos, Nicholas ; Ong, Shin Yeu ; Xu, Mingge; Chng, Wee Joo ; Goh, Yeow Tee ; Nagarajan, Chandramouli
220-Sep-2018Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosisTeoh, Phaik Ju ; An, Omer ; Chung, Tae-Hoon ; Chooi, Jing Yuan ; Toh, Sabrina HM ; Fan, Shuangyi ; Wang, Wilson ; Koh, Bryan TH; Fullwood, Melissa J ; Ooi, Melissa G ; de Mel, Sanjay; Soekojo, Cinnie Y; Chen, Leilei ; Ng, Siok Bian ; Yang, Henry ; Chng, Wee Joo 
31-Mar-2011Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profilingNg, Siok-Bian ; Selvarajan, Viknesvaran; Huang, Gaofeng; Zhou, Jianbiao ; Feldman, Andrew L; Law, Mark; Kwong, Yok-Lam; Shimizu, Norio; Kagami, Yoshitoyo; Aozasa, Katsuyuki; Salto-Tellez, Manuel; Chng, Wee-Joo 
423-Feb-2021Application of Advanced Mass Spectrometry-Based Proteomics to Study Hypoxia Driven Cancer ProgressionVinaiphat, Arada; Low, Jee Keem; Yeoh, Kheng Wei ; Chng, Wee Joo ; Sze, Siu Kwan
51-Jan-2016Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligenceAbid, Muhammad Bilal; De Mel, Sanjay; Abid, Muhammad Abbas; Tan, Kong Bing; Chng, Wee Joo 
629-Apr-2021CAR T-cell therapy in multiple myeloma: more room for improvementTeoh, Phaik Ju ; Chng, Wee Joo 
71-Jun-2017Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVORChng, W-J ; Goldschmidt, H; Dimopoulos, MA; Moreau, P; Joshua, D; Palumbo, A; Facon, T; Ludwig, H; Pour, L; Niesvizky, R; Oriol, A; Rosinol, L; Suvorov, A; Gaidano, G; Pika, T; Weisel, K; Goranova-Marinova, V; Gillenwater, HH; Mohamed, N; Feng, S; Aggarwal, S; Hajek, R
816-Aug-2021Chromatin interaction neural network (ChINN): a machine learning-based method for predicting chromatin interactions from DNA sequencesCao, Fan ; Zhang, Yu; Cai, Yichao; Animesh, Sambhavi; Zhang, Ying; Akincilar, Semih Can; Loh, Yan Ping; Li, Xinya; Chng, Wee Joo ; Tergaonkar, Vinay ; Kwoh, Chee Keong; Fullwood, Melissa J 
920-Oct-2020Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)Liu, Jin; Hu, Xiaoxia; Jia, Yanchun; Lu, Jin; Lee, Jae Hoon; Kim, Kihyun; Chen, Wenming; Liu, Aijun; Liu, Yang; Chen, Q; Zhang, Chunyang; Suh, Cheolwon; Kim, Min Kyoung; Zhou, Fan; Chng, Wee Joo ; Kumar, Shaji K; Durie, Brian; Hou, Jian; Fu, Weijun; Du, Juan
101-Nov-2019Comprehensive Analysis of ERK1/2 Substrates for Potential Combination ImmunotherapiesYang, Lei ; Zheng, Liangzhen; Chng, Wee Joo ; Ding, Jeak Ling 
111-Aug-2016Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaMadan, V ; Shyamsunder, P ; Han, L; Mayakonda, A ; Nagata, Y; Sundaresan, J ; Kanojia, D ; Yoshida, K; Ganesan, S; Hattori, N; Fulton, N; Tan, KT ; Alpermann, T; Kuo, MC; Rostami, S; Matthews, J; Sanada, M; Liu, L-Z ; Shiraishi, Y; Miyano, S; Chendamarai, E; Hou, HA; Malnassy, G; Ma, T; Garg, M ; Ding, LW ; Sun, QY ; Chien, W ; Ikezoe, T; Lill, M; Biondi, A; Larson, RA; Powell, BL; Lubbert, M; Chng, WJ ; Tien, HF; Heuser, M; Ganser, A; Koren-Michowitz, M; Kornblau, SM; Kantarjian, HM; Nowak, D; Hofmann, WK; Yang, H ; Stock, W; Ghavamzadeh, A; Alimoghaddam, K; Haferlach, T; Ogawa, S; Shih, LY; Mathews, V; Koeffler, HP 
121-Dec-2016Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (vol 30, pg 1672, 2016)Madan, V ; Shyamsunder, P ; Han, L; Mayakonda, A ; Nagata, Y; Sundaresan, J ; Kanojia, D ; Yoshida, K; Ganesan, S; Hattori, N; Fulton, N; Tan, KT ; Alpermann, T; Kuo, MC; Rostami, S; Matthews, J; Sanada, M; Liu, L-Z ; Shiraishi, Y; Miyano, S; Chendamarai, E; Hou, HA; Malnassy, G; Ma, T; Garg, M ; Ding, LW ; Sun, QY ; Chien, W ; Ikezoe, T; Lill, M; Biondi, A; Larson, RA; Powell, BL; Lubbert, M; Chng, WJ ; Tien, HF; Heuser, M; Ganser, A; Koren-Michowitz, M; Kornblau, SM; Kantarjian, HM; Nowak, D; Hofmann, WK; Yang, H ; Stock, W; Ghavamzadeh, A; Alimoghaddam, K; Haferlach, T; Ogawa, S; Shih, LY; Mathews, V; Koeffler, HP 
131-Dec-2016Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (vol 30, pg 1672, 2016)Madan, V ; Shyamsunder, P ; Han, L; Mayakonda, A ; Nagata, Y; Sundaresan, J ; Kanojia, D ; Yoshida, K; Ganesan, S; Hattori, N; Fulton, N; Tan, KT ; Alpermann, T; Kuo, MC; Rostami, S; Matthews, J; Sanada, M; Liu, L-Z ; Shiraishi, Y; Miyano, S; Chendamarai, E; Hou, HA; Malnassy, G; Ma, T; Garg, M ; Ding, LW ; Sun, QY ; Chien, W ; Ikezoe, T; Lill, M; Biondi, A; Larson, RA; Powell, BL; Lubbert, M; Chng, WJ ; Tien, HF; Heuser, M; Ganser, A; Koren-Michowitz, M; Kornblau, SM; Kantarjian, HM; Nowak, D; Hofmann, WK; Yang, H ; Stock, W; Ghavamzadeh, A; Alimoghaddam, K; Haferlach, T; Ogawa, S; Shih, LY; Mathews, V; Koeffler, HP 
1418-Feb-2021Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myelomaXiong, Sinan; Chng, Wee-Joo ; Zhou, Jianbiao 
151-Mar-2021Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysisChong, Lip Leong; Soon, Yu Yang ; Soekojo, Cinnie Yentia; Ooi, Melissa ; Chng, Wee Joo ; de Mel, Sanjay
1616-Oct-2021DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypesKizhakeyil, Atish; Zaini, Nurmahirah Binte Mohammed; Poh, Zhi Sheng; Wong, Brandon Han Siang; Loh, Xinpeng; Ng, Aik Seng; Low, Zun Siong; Prasannan, Praseetha; Gong, Chun; Tan, Michelle Guet Khim; Nagarajan, Chandramouli; Huang, Dachuan; Lu, Pang Wan; Lim, Jing Quan; Barrans, Sharon; Ong, Choon Kiat; Lim, Soon Thye; Chng, Wee Joo ; Follows, George; Hodson, Daniel J; Du, Ming Qing; Goh, Yeow Tee; Tan, Suat Hoon; Grigoropoulos, Nicholas Francis; Verma, Navin Kumar
1723-Apr-2020Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaGoldschmidt, Hartmut; Dimopoulos, Meletios A; Rajkumar, S Vincent; Weisel, Katja C; Moreau, Philippe; Chng, Wee-Joo ; Mikala, Gabor; Cavo, Michele; Ramasamy, Karthik; Suryanarayan, Kaveri; Teng, Zhaoyang; Labotka, Richard; Victoria Mateos, Maria
1810-Jun-2020Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup AnalysisHuang, Shang-Yi; Yoon, Sung-Soo; Shimizu, Kazuyuki; Chng, Wee Joo ; Chang, Cheng-Shyong; Wong, Raymond Siu-Ming; Gao, Seasea; Wang, Yang; Gordon, Steve W; Glennane, Anthony; Min, Chang-Ki
191-Jan-2021Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphomaMustafa, Nurulhuda ; Nee, Adina Huey Fang ; Chooi, Jing Yuan ; Toh, Sabrina Hui Min ; Chung, Tae-Hoon ; Selvarajan, Viknesvaran ; Fan, Shuangyi ; Ng, Siok Bian ; Poon, Michelle ; Chan, Esther ; Lee, Joanne; Chee, Yen Lin ; Jeyasekharan, Anand D ; Zhou, Longen; Yang, Jennifer; Chng, Wee Joo 
203-Nov-2011Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaNg, Siok-Bian ; Yan, Junli ; Huang, Gaofeng ; Selvarajan, Viknesvaran; Tay, Jim Liang-Seah; Lin, Baohong; Bi, Chonglei; Tan, Joy; Kwong, Yok-Lam; Shimizu, Norio; Aozasa, Katsuyuki; Chng, Wee-Joo